The global medical device analytical testing outsourcing market is entering a period of strong expansion as medical device manufacturers increasingly rely on specialized third-party laboratories for quality, safety, validation, and regulatory testing. According to the newly released analysis by Transparency Market Research, the market was valued at US$5.3 billion in 2021 and is projected to reach US$16.7 billion by 2032, expanding at a CAGR of 11.2% between 2022 and 2032. Outsourcing enables manufacturers to reduce operational costs, minimize business risks, access advanced analytical technologies, and accelerate product commercialization. Growing complexity in medical devices, increasing regulatory scrutiny, and the need for accurate testing are encouraging companies to work with specialized service providers for material characterization, sterility, bioburden, physical testing, extractable and leachable studies, and other analytical requirements.
👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85237
Market Size and Growth
The market expanded at approximately 8.2% CAGR between 2017 and 2021, demonstrating increasing acceptance of outsourced testing models across the medical device industry. During the forecast period, growth is expected to accelerate substantially, with the market increasing from approximately US$5.8 billion in 2022 to US$16.7 billion by 2032. Medical device companies are outsourcing testing because maintaining every specialized testing capability internally can require substantial investment in infrastructure, skilled personnel, validation, and sophisticated equipment. Regulatory requirements are also becoming increasingly demanding, particularly for implantable and technologically advanced devices. Analytical evaluation, accelerated testing, material assessment, and extractables and leachables testing can help manufacturers identify potential risks before products reach the market, thereby reducing costly redesigns, recalls, and regulatory delays.
Market Segmentation
By service, material characterization is expected to remain a major growth area, with the segment projected to expand at approximately 12.5% CAGR during 2022–2032. Increasing demand for detailed evaluation of device materials, including their molecular, elemental, crystalline, and structural properties, is supporting adoption. Extractable and leachable testing is also gaining importance as manufacturers seek to determine whether substances can migrate from device materials into surrounding environments, drug products, or patients. By therapeutic area, cardiology is projected to be the fastest-growing segment, recording a CAGR of more than 12.8% during the forecast period. Increasing development of cardiovascular devices such as heart valves, coronary stents, endovascular grafts, and angioplasty balloon catheters is expected to support demand for specialized analytical testing.
Regional Analysis
Asia Pacific is projected to remain a leading opportunity within the medical device analytical testing outsourcing market, supported by expanding healthcare infrastructure, increasing medical device manufacturing, and growing adoption of outsourcing services. North America is also expected to represent a significant market because of its established medical device manufacturing ecosystem and demand for sophisticated, high-reliability devices. In country-level markets, the U.S. is expected to remain a major contributor. The U.K. market is projected to reach US$549 million by 2032, while Japan is expected to expand at a CAGR of 13.2%, reaching approximately US$1.3 billion by 2032.
Competitive Landscape
The competitive environment includes established testing, research, and contract service organizations offering increasingly comprehensive analytical capabilities. Key companies profiled include SGS SA, Toxikon, Inc., Eurofins Scientific, Pace Analytical Services, LLC, Intertek Group plc, WuXi AppTec, North American Science Associates Inc., Envigo, Charles River Laboratories International Inc., and Medical Device Testing Services. Market participants are pursuing collaborations, acquisitions, laboratory expansions, service portfolio development, and regional expansion to strengthen their competitive positions.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453